Immunotherapie voor pediatrische en volwassen Glioblastoma patiënten: naar een op tumor-immuun interacties gedreven precisie geneeskunde met behulp van ruimtelijke radio-multiomics.
Identificatie van nanobodies tegen immunomodulerende checkpoint receptoren in glioblastoma tumorcellen
Functionele precisie kankergeneeskunde: Next-generation behandeling voor glioblastoma De heterogeniteit van medicijn-respons in kaart brengen, gebruikmakend van single cell protein analyse
Toward more accurate preclinical glioblastoma modeling: Reverse translation of clinical standard of care in a glioblastoma mouse model.
Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma : a preclinical F98 glioblastoma rat model study
CHARACTERIZATION OF BMP SYSTEM MUTATIONS IN RECURRENT PRIMARY GLIOBLASTOMA PRIMARY CELL CULTURES IN RELATION TO GLIOBLASTOMA INITIATING STEM-LIKE CELLS AND TEMOZOLOMIDE RESISTANCE
Cost-effectiveness of [18F] fluoroethyl-L-tyrosine for temozolomide therapy assessment in patients with glioblastoma
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy
Replication Data for: Loss of INPP5K attenuates agonist-induced Ca2+ responses in the glioblastoma cell line U-251 MG cells